{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:48:44Z","timestamp":1776084524891,"version":"3.50.1"},"reference-count":136,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Diabetes mellitus (DM) is a complex metabolic disorder associated with a heightened risk of cardiovascular events, largely driven by a hypercoagulable and hypofibrinolytic state. The pathophysiological interplay between chronic hyperglycemia, oxidative stress, insulin resistance, and systemic inflammation fosters profound alterations in the coagulation cascade, endothelial function, and platelet activity. This narrative review synthesizes evidence from studies published between 2008 and 2026, focusing on coagulation and platelet-related biomarkers selected based on their biological relevance to thrombosis, endothelial dysfunction, and inflammation, as well as the availability of clinical and interventional data across different forms of DM. Although there are numerous biomarkers involved in the pathogenesis of various forms of diabetes, this narrative review critically examines key coagulation biomarkers\u2014including D-dimer, fibrinogen, prothrombin, tissue thromboplastin or tissue factor, P-selectin, soluble urokinase plasminogen activator receptor, thrombomodulin, plasminogen activator inhibitor-1, von Willebrand factor, and \u03b2-thromboglobulin\u2014across distinct diabetes subtypes, including type 1, type 2, gestational, and secondary forms linked to endocrinopathies and pancreatic diseases. The literature reveals substantial subtype-specific heterogeneity in hemostatic alterations. For instance, Type 1 DM is characterized by early endothelial dysfunction and platelet activation, while Type 2 DM presents with elevated coagulation factors, impaired fibrinolysis, and a proinflammatory milieu. Gestational DM exhibits pregnancy-specific changes in coagulation, yet distinguishing them from obesity-related effects remains challenging. Secondary diabetes forms, such as those associated with Cushing\u2019s syndrome or pancreatitis, further underscore the diversity in thrombotic risk profiles. Among the coagulation and platelet activation biomarkers reviewed, fibrinogen, P-selectin, and plasminogen activator inhibitor-1 demonstrate the most consistent associations with glycemic control, vascular dysfunction, and therapeutic modulation, particularly in type 2 diabetes, suggesting greater potential for clinical translation. In contrast, evidence for markers such as D-dimer, tissue factor or tissue thromboplastin, and soluble urokinase plasminogen activator receptor remains heterogeneous and insufficient for routine clinical application. By synthesizing mechanistic insights and clinical data, this review highlights the urgent need for subtype-tailored coagulation assessment in diabetes management. A better understanding of the dynamic alterations in coagulation pathways may facilitate earlier detection of vascular complications and inform personalized antithrombotic strategies.<\/jats:p>","DOI":"10.3390\/life16040648","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:38:26Z","timestamp":1776080306000},"page":"648","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Narrative Review on Abnormalities in the Hemostatic System in Diabetes Mellitus: Pathophysiology, Clinical Implications, and Therapeutics"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8043-9667","authenticated-orcid":false,"given":"Sana","family":"Rafaqat","sequence":"first","affiliation":[{"name":"Department of Biotechnology (Human Genetics), Lahore College for Women University, Lahore 44444, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3859-0152","authenticated-orcid":false,"given":"Hafsa","family":"Hamid","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Lahore College for Women University, Lahore 44444, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fakhra","family":"Bashir","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Lahore College for Women University, Lahore 44444, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hijab","family":"Abaid","sequence":"additional","affiliation":[{"name":"School of Biochemistry and Biotechnology, University of the Punjab, Lahore 54590, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7870-0996","authenticated-orcid":false,"given":"Aleksandra","family":"Klisic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Montenegro, 81000 Podgorica, Montenegro"},{"name":"Center for Laboratory Diagnostics, Primary Health Care Center, 81000 Podgorica, Montenegro"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7177-5602","authenticated-orcid":false,"given":"Saira","family":"Rafaqat","sequence":"additional","affiliation":[{"name":"Department of Zoology, Lahore College for Women University, Lahore 44444, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-1534","authenticated-orcid":false,"given":"Filiz","family":"Mercantepe","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Duzce University, Duzce 81620, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2025). Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142025. Diabetes Care, 48, S27\u2013S49.","DOI":"10.2337\/dc25-S002"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/ajm.ajm_53_20","article-title":"Pathophysiology of Diabetes: An Overview","volume":"10","author":"Banday","year":"2020","journal-title":"Avicenna J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Safdar, N.Z., Kietsiriroje, N., and Ajjan, R.A. (2023). The Cellular and Protein Arms of Coagulation in Diabetes: Established and Potential Targets for the Reduction of Thrombotic Risk. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242015328"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1538-7836.2010.03910.x","article-title":"Hyperglycemia: A Prothrombotic Factor?","volume":"8","author":"Lemkes","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/BF00401055","article-title":"Coagulation Activation in Diabetes Mellitus: The Role of Hyperglycaemia and Therapeutic Prospects","volume":"36","author":"Ceriello","year":"1993","journal-title":"Diabetologia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7489795","DOI":"10.1155\/2020\/7489795","article-title":"Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications","volume":"2020","author":"Papachristoforou","year":"2020","journal-title":"J. Diabetes Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2147\/DMSO.S349412","article-title":"The Prevalence of Coagulopathy and Associated Factors Among Adult Type II Diabetes Mellitus Patients Attending the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia","volume":"15","author":"Getu","year":"2022","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/0974-2727.180790","article-title":"Is There a Tendency for Thrombosis in Gestational Diabetes Mellitus?","volume":"8","author":"Gorar","year":"2016","journal-title":"J. Lab. Physicians"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Barale, C., and Russo, I. (2020). Influence of Cardiometabolic Risk Factors on Platelet Function. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020623"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Sobczak, A.I.S., and Stewart, A.J. (2019). Coagulatory Defects in Type-1 and Type-2 Diabetes. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20246345"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Goto, S. (2020). Mechanism of thrombus formation in regard to diet. New Insights into Metabolic Syndrome, IntechOpen.","DOI":"10.5772\/intechopen.92382"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11897-024-00671-z","article-title":"The Role of Coagulation in Heart Failure: A Literature Review","volume":"21","author":"Anjum","year":"2024","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Domingueti, C.P., Dusse, L.M.S., F\u00f3scolo, R.B., Reis, J.S., Annichino-Bizzacchi, J.M., De Andrade Orsi, F.L., De Moraes Mazetto, B., Das Gra\u00e7as Carvalho, M., Gomes, K.B., and Fernandes, A.P. (2015). Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132784"},{"key":"ref_14","first-page":"657","article-title":"D-Dimer Levels in Type 1 and Type 2 Diabetic Children and Adolescents; Relation to Microvascular Complications and Dyslipidemia \u201cown Data and Review","volume":"3","author":"Adly","year":"2012","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.numecd.2022.05.013","article-title":"Association of D-Dimer with Long-Term Prognosis in Type 2 Diabetes Mellitus Patients with Acute Coronary Syndrome","volume":"32","author":"Zhou","year":"2022","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_16","first-page":"BC18","article-title":"Association of D-Dimer Level with Renal Parameters and Cardiovascular Events in Type 2 Diabetes Mellitus: A Retrospective Cohort Study","volume":"17","author":"Patel","year":"2023","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2174\/1567205016666190321164741","article-title":"Elevated Plasma Level of D-Dimer Predicts the High Risk of Early Cognitive Impairment in Type 2 Diabetic Patients as Carotid Artery Plaques Become Vulnerable or Get Aggravated","volume":"16","author":"Wang","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Zhuang, L., Yu, C., Xu, F., Zhao, L.H., Wang, X.H., Wang, C.H., Ning, L.Y., Zhang, X.L., Zhang, D.M., and Wang, X.Q. (2022). Increased Plasma D-Dimer Levels May Be a Promising Indicator for Diabetic Peripheral Neuropathy in Type 2 Diabetes. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.930271"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF00569421","article-title":"Increased Prothrombin Fragment 1+2 and D-Dimer in First Degree Relatives of Type 2 Diabetic Patients","volume":"33","author":"Camps","year":"1996","journal-title":"Acta Diabetol."},{"key":"ref_20","first-page":"145","article-title":"Correlation between HbA1C and D-Dimer in Type 2 Diabetic with COVID-19 Patients","volume":"3","author":"Pangaribuan","year":"2021","journal-title":"J. Endocrinol. Trop. Med. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3192350","DOI":"10.1155\/2020\/3192350","article-title":"Reference Values of D-Dimers and Fibrinogen in the Course of Physiological Pregnancy: The Potential Impact of Selected Risk Factors-A Pilot Study","volume":"2020","author":"Siennicka","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.15296\/ijwhr.2019.03","article-title":"Evaluation of Plasma D-Dimer Concentration among Normal and Complicated Pregnancies, Saudi Arabia","volume":"7","author":"Zaini","year":"2019","journal-title":"Int. J. Women\u2019s Health Reprod. Sci."},{"key":"ref_23","first-page":"1","article-title":"Changes of D Dimer in Women with Gestational Diabetes and Healthy Women after Elective Cesarean Section","volume":"22","author":"Mallah","year":"2021","journal-title":"Iran. J. Obstet. Gynecol. Infertil."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/17474124.2022.2116314","article-title":"Preexisting Diabetes, Serum Calcium and D-Dimer Levels as Predictable Risk Factors for Pancreatic Necrosis of Patients with Acute Pancreatitis: A Retrospective Study","volume":"16","author":"Xue","year":"2022","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"12952","DOI":"10.1038\/s41598-022-17421-7","article-title":"Triglyceride to HDL-C Ratio Is Associated with Plasma D-Dimer Levels in Different Types of Pancreatitis","volume":"12","author":"Jia","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/ijabmr.ijabmr_483_23","article-title":"D-Dimer as a Marker of Severity and Prognosis in Acute Pancreatitis","volume":"14","author":"Newton","year":"2024","journal-title":"Int. J. Appl. Basic Med. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.17727\/JMSR.2024\/12-52","article-title":"D-Dimer as a Predictor of Severity and Outcome in Acute Pancreatitis","volume":"12","author":"Joseph","year":"2024","journal-title":"J. Med. Sci. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1507\/endocrj.EJ14-0102","article-title":"D-Dimer as a Significant Marker of Deep Vein Thrombosis in Patients with Subclinical or Overt Cushing\u2019s Syndrome","volume":"61","author":"Fukuoka","year":"2014","journal-title":"Endocr. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.2147\/DMSO.S309068","article-title":"Blood Levels of Glycated Hemoglobin, D-Dimer, and Fibrinogen in Diabetic Retinopathy","volume":"14","author":"Zhao","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2285868","DOI":"10.1080\/0886022X.2023.2285868","article-title":"Plasma D-Dimer Levels Are Associated with Disease Progression in Diabetic Nephropathy: A Two-Center Cohort Study","volume":"45","author":"Yu","year":"2023","journal-title":"Ren. Fail."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.18203\/2320-6012.ijrms20162613","article-title":"Study of Plasma Fibrinogen Level and Its Relation to Glycemic Control in Type-2 Diabetes Mellitus Patients Attending Diabetes Clinic at a Tertiary Care Teaching Hospital in Madhya Pradesh, India","volume":"9","author":"Gupta","year":"2016","journal-title":"Int. J. Res. Med. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12288-011-0116-9","article-title":"A Study of Plasma Fibrinogen Level in Type-2 Diabetes Mellitus and Its Relation to Glycemic Control","volume":"28","author":"Bembde","year":"2012","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1210\/jcem.85.9.6779","article-title":"Increased Fibrinogen Production in Type 2 Diabetic Patients without Detectable Vascular Complications: Correlation with Plasma Glucagon Concentrations","volume":"85","author":"Barazzoni","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.dsx.2019.01.049","article-title":"The Importance of Measurement of Plasma Fibrinogen Level among Patients with Type- 2 Diabetes Mellitus","volume":"13","author":"Sultan","year":"2019","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1172\/JCI109326","article-title":"Reduced Fibrinogen Survival in Diabetes Mellitus. A Reversible Phenomenon","volume":"63","author":"Jones","year":"1979","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1479164120963048","article-title":"Maturity Onset Diabetes of the Young and Fibrin-Related Thrombosis Risk","volume":"17","author":"Sagar","year":"2020","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/cen.13521","article-title":"Translational Evidence of Prothrombotic and Inflammatory Endothelial Damage in Cushing Syndrome after Remission","volume":"88","author":"Aranda","year":"2018","journal-title":"Clin. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1053\/meta.2001.25656","article-title":"Effect of the Inflammation, Chronic Hyperglycemia, or Malabsorption on the Apolipoprotein A-IV Concentration in Type 1 Diabetes Mellitus and in Diabetes Secondary to Chronic Pancreatitis","volume":"50","author":"Quilliot","year":"2001","journal-title":"Metabolism"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Sui, Y., Zhao, Z., Zhang, Y., Zhang, T., Li, G., Liu, L., Tan, H., Sun, B., and Li, L. (2022). Fibrinogen-like Protein 1 as a Predictive Marker for the Incidence of Severe Acute Pancreatitis and Infectious Pancreatic Necrosis. Medicina, 58.","DOI":"10.3390\/medicina58121753"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12020-009-9186-y","article-title":"Hypercoagulability in Cushing\u2019s Syndrome: The Role of Specific Haemostatic and Fibrinolytic Markers","volume":"36","author":"Kastelan","year":"2009","journal-title":"Endocrine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF03345709","article-title":"Blood Coagulation and Fibrinolysis in Patients with Cushing\u2019s Syndrome: Increased Plasminogen Activator Inhibitor-I, Decreased Tissue Factor Pathway Inhibitor, and Unchanged Thrombin-Activatable Fibrinolysis Inhibitor Levels","volume":"32","author":"Erem","year":"2009","journal-title":"J. Endocrinol. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2265.1997.d01-1743.x","article-title":"Elevated Fibrinogen Levels Decrease Following Treatment of Acromegaly","volume":"46","author":"Tengborn","year":"1997","journal-title":"Clin. Endocrinol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kyriakakis, N., Lynch, J., Seejore, K., Phoenix, F., Oxley, N., Orme, S., Ajjan, R., and Murray, R. (2019). SUN-075 Higher Fibrinogen and Clot Density in Patients with Acromegaly: The Role of Adverse Body Composition to the Increased Thrombotic Potential. J. Endocr. Soc., 3.","DOI":"10.1210\/js.2019-SUN-075"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-2000-8145","article-title":"Alterations of Haemostatic and Fibrinolytic Markers in Adult Patients with Growth Hormone Deficiency and with Acromegaly","volume":"108","author":"Sartorio","year":"2000","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13098-021-00777-7","article-title":"Fibrinogen Function Indexes Are Potential Biomarkers of Diabetic Peripheral Neuropathy","volume":"14","author":"Zhuang","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0038-1650578","article-title":"Elevated Circulating P-Selectin in Insulin Dependent Diabetes Mellitus","volume":"76","author":"Jilma","year":"1996","journal-title":"Thromb. Haemost."},{"key":"ref_47","first-page":"23","article-title":"Elevated Levels of Soluble E-Selectin and P-Selectin in Patients with NIDDM","volume":"22","author":"Yoo","year":"1998","journal-title":"Korean Diabetes Assoc."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4239\/wjd.v6.i3.423","article-title":"Endothelial and Platelet Markers in Diabetes Mellitus Type 2","volume":"6","author":"Kubisz","year":"2015","journal-title":"World J. Diabetes"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1152\/ajpheart.1999.277.2.H763","article-title":"Reperfusion Injury Is Not Affected by Blockade of P-Selectin in the Diabetic Mouse Heart","volume":"277","author":"Jones","year":"1999","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_50","first-page":"77","article-title":"Role of Soluble P-Selectin among Type 2 Diabetic Patients with and without Coronary Heart Disease","volume":"30","author":"Ali","year":"2012","journal-title":"Egypt. J. Biochem. Mol. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/10245330500072405","article-title":"Soluble P-Selectin Levels in Diabetes Mellitus Patients with Coronary Artery Disease","volume":"10","author":"Aref","year":"2005","journal-title":"Hematology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.diabet.2018.04.004","article-title":"Platelet Function Following Induced Hypoglycaemia in Type 2 Diabetes","volume":"44","author":"Kahal","year":"2018","journal-title":"Diabetes Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1523-1755.2005.00452.x","article-title":"P-Selectin Gene Haplotype Associations with Albuminuria in the Diabetes Heart Study","volume":"68","author":"Liu","year":"2005","journal-title":"Kidney Int."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"103579","DOI":"10.1016\/j.sjbs.2023.103579","article-title":"The Impact of SELP Gene Thr715Pro Polymorphism on SP-Selectin Level and Association with Cardiovascular Disease in Saudi Diabetic Patients: A Cross-Sectional Case-Control Study","volume":"30","author":"Alzahrani","year":"2023","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-020-00548-x","article-title":"Putative Functional Non-Coding Polymorphisms in SELP Significantly Modulate SP-Selectin Levels, Arterial Stiffness and Type 2 Diabetes Mellitus Susceptibility","volume":"20","author":"Kaur","year":"2020","journal-title":"BMC Endocr. Disord."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/09513590.2022.2164762","article-title":"Differentiated Serum Levels of Kr\u00fcppel-like Factors 2 and 4, SP-Selectin, and SE-Selectin in Patients with Gestational Diabetes Mellitus","volume":"38","author":"Zhang","year":"2022","journal-title":"Gynecol. Endocrinol."},{"key":"ref_57","first-page":"13","article-title":"Impaired Microvascular Reactivity and Endothelial Function in Patients with Cushing\u2019s Syndrome: Influence of Arterial Hypertension","volume":"57","author":"Pecen","year":"2008","journal-title":"Physiol. Res."},{"key":"ref_58","first-page":"279037","article-title":"Leukocyte Adhesion Molecules in Diabetic Retinopathy","volume":"2012","author":"Noda","year":"2012","journal-title":"J. Ophthalmol."},{"key":"ref_59","first-page":"S343","article-title":"The Role of Adhesion Molecules and Cytokines in Patients with Diabetic Nephropathy","volume":"2016","author":"Avci","year":"2016","journal-title":"Biomed. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jdiacomp.2019.06.001","article-title":"Soluble Urokinase Plasminogen Activator Receptor in Type 1 Diabetic Children, Relation to Vascular Complications","volume":"33","author":"Sherif","year":"2019","journal-title":"J. Diabetes Complicat."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/joim.12269","article-title":"Soluble Urokinase Plasminogen Activator Receptor Levels Are Elevated and Associated with Complications in Patients with Type 1 Diabetes","volume":"277","author":"Theilade","year":"2015","journal-title":"J. Intern. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"40627","DOI":"10.1038\/srep40627","article-title":"Soluble Urokinase Receptor (SuPAR) Predicts Microalbuminuria in Patients at Risk for Type 2 Diabetes Mellitus","volume":"7","author":"Guthoff","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2337\/dc18-1427","article-title":"Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients with Type 1 Diabetes","volume":"42","author":"Curovic","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00125-013-2914-0","article-title":"The Pro-Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor (SuPAR) Is Associated with Incident Type 2 Diabetes among Overweight but Not Obese Individuals with Impaired Glucose Regulation: Effect Modification by Smoking and Body Weight","volume":"56","author":"Heraclides","year":"2013","journal-title":"Diabetologia"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"20-LB","DOI":"10.2337\/db23-20-LB","article-title":"20-LB: Impact of Optimal Medical Therapy, Insulin Sensitization, and Revascularization Strategies on Soluble Urokinase Plasminogen Activator Receptor and Its Association with Cardiovascular Outcomes\u2014A BARI-2D Ancillary Study","volume":"72","author":"Amadi","year":"2023","journal-title":"Diabetes"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4236\/jdm.2011.14013","article-title":"Soluble Urokinase-Plasminogen Activator Receptor (SuPAR) and Natural Phosphorylcholine IgM Antibodies in Patients at Clinical Onset of Diabetes Mellitus","volume":"1","author":"Hillman","year":"2011","journal-title":"J. Diabetes Mellit."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1464-5491.2011.03513.x","article-title":"The Immune Marker Soluble Urokinase Plasminogen Activator Receptor Is Associated with New-Onset Diabetes in Non-Smoking Women and Men","volume":"29","author":"Haugaard","year":"2012","journal-title":"Diabet. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"154","DOI":"10.34172\/jcvtr.2023.32895","article-title":"Plasminogen Activator Urokinase Receptor as a Diagnostic and Prognostic Biomarker in Type 2 Diabetic Patients with Cardiovascular Disease","volume":"15","author":"Mohammed","year":"2023","journal-title":"J. Cardiovasc. Thorac. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e1214","DOI":"10.1210\/clinem\/dgad301","article-title":"Risk Estimation of Gestational Diabetes Mellitus in the First Trimester","volume":"108","author":"Gerszi","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0016-5085(97)70186-0","article-title":"Enhanced Urokinase Plasminogen Activation in Chronic Pancreatitis Suggests a Role in Its Pathogenesis","volume":"113","author":"Friess","year":"1997","journal-title":"Gastroenterology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"109116","DOI":"10.1016\/j.diabres.2021.109116","article-title":"Serum Soluble Urokinase Plasminogen Activator Receptor as a Potential Biomarker of Renal Impairment Severity in Diabetic Nephropathy","volume":"182","author":"Sorohan","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/23744235.2019.1688387","article-title":"The Role of Soluble Urokinase Plasminogen Activator Receptor (SuPAR) in the Diagnostics of Diabetic Foot Infection","volume":"52","author":"Aslan","year":"2020","journal-title":"Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0268-9499(94)90234-8","article-title":"The Effect of the Relationship between Tissue-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1 on Tissue-Type Plasminogen Activator Activity in Insulin-Dependent Diabetes Mellitus","volume":"8","author":"Myrup","year":"1994","journal-title":"Fibrinolysis Proteolysis"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/01.STR.27.4.712","article-title":"Brain Capillary Tissue Plasminogen Activator in a Diabetes Stroke Model","volume":"27","author":"Kittaka","year":"1996","journal-title":"Stroke"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1203\/01.PDR.0000049509.65496.BF","article-title":"Von Willebrand Factor and Its Propeptide in Children with Diabetes. Relation between Endothelial Dysfunction and Microalbuminuria","volume":"53","author":"Verrotti","year":"2003","journal-title":"Pediatr. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1161\/CIRCULATIONAHA.108.792986","article-title":"Von Willebrand Factor, Type 2 Diabetes and Risk of Cardiovascular Disease","volume":"118","author":"Frankel","year":"2008","journal-title":"Circulation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e3193","DOI":"10.1002\/dmrr.3193","article-title":"Plasma Levels of von Willebrand Factor in Type 2 Diabetes Patients with and without Cardiovascular Diseases: A Meta-Analysis","volume":"36","author":"Peng","year":"2020","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.14260\/jemds\/2016\/1372","article-title":"Role of Von Willebrand Factor in Type 2 Diabetes Mellitus Patients","volume":"5","author":"Umadevi","year":"2016","journal-title":"J. Evol. Med. Dent. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Chen, Y., Huang, D., Liu, J., Zeng, F., Tang, G., Lei, W., Wang, H., Jiang, Y., Shentu, W., and Wang, H. (2021). Non-Invasive Detection of Fetal Vascular Endothelial Function in Gestational Diabetes Mellitus. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.763683"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-0043-100113","article-title":"Coagulation Profile in Patients with Different Etiologies for Cushing Syndrome: A Prospective Observational Study","volume":"49","author":"Tirosh","year":"2017","journal-title":"Horm. Metab. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s40618-020-01186-9","article-title":"The Haemostatic System in Acromegaly: A Single-Centre Case\u2013Control Study","volume":"43","author":"Campello","year":"2020","journal-title":"J. Endocrinol. Investig."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/diab.40.8.971","article-title":"Von Willebrand Factor and Development of Diabetic Nephropathy in IDDM","volume":"40","author":"Stehhouwer","year":"1991","journal-title":"Diabetes"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V126.23.2240.2240","article-title":"ADAMTS13\/VWF Axis Potentially Contributes to Diabetic Nephropathy By Regulating PAI-1 Levels","volume":"126","author":"Dhanesha","year":"2015","journal-title":"Blood"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Cobert, B.L., Smit Sibinga, C.T., and Das, P.C. (1982). Beta-thromboglobulin: A story of value?. Bloodtransfusion and Problems of Bleeding, Springer.","DOI":"10.1007\/978-94-009-7692-4"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1600-0609.1979.tb02743.x","article-title":"Beta Thromboglobulin and Glycosylated Haemoglobin in Diabetes Mellitus","volume":"23","author":"Matthews","year":"1979","journal-title":"Scand. J. Haematol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/00365519009091602","article-title":"Primary Platelet Activation in Recent-Onset Type 1 Diabetes Mellitus","volume":"50","author":"Vicari","year":"1990","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2337\/diacare.7.2.174","article-title":"Plasma Beta-Thromboglobulin, Platelet Factor 4, Fibrinopeptide A, and Other Hemostatic Functions during Improved, Short-Term Glycemic Control in Diabetes Mellitus","volume":"7","author":"Rosove","year":"1984","journal-title":"Diabetes Care"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02591091","article-title":"\u0392-Thromboglobulin and Fibrinopeptide a in Diabetes Mellitus As Markers of Vascular Damage","volume":"22","author":"Librenti","year":"1985","journal-title":"Acta Diabetol. Lat."},{"key":"ref_89","first-page":"1911","article-title":"Binds to a Ligand on Macrophages","volume":"27","author":"Preston","year":"1997","journal-title":"Cell. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1661186","article-title":"Platelet Aggregation, Beta-Thromboglobulin and Platelet Factor 4 in Diabetes Mellitus and in Patients with Vasculopathy","volume":"52","author":"Fritschi","year":"1984","journal-title":"Thromb. Haemost."},{"key":"ref_91","first-page":"5","article-title":"Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) in Type 2 Diabetes Mellitus, a Case Control Study","volume":"5","author":"Thukral","year":"2018","journal-title":"Int. J. Contemp. Med. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1538-7836.2007.02366.x","article-title":"Elevated Prothrombin Level and Shortened Clotting Times in Subjects with Type 2 Diabetes","volume":"5","author":"Sauls","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"108","DOI":"10.37962\/jbas.v12i2.428","article-title":"Assessment of Variations in PT, APTT and Platelet Count and Their Correlation with Glycated Hemoglobin in Type 2 Diabetes Mellitus","volume":"12","author":"Ahmad","year":"2021","journal-title":"RADS J. Biol. Res. Appl. Sci."},{"key":"ref_94","first-page":"492","article-title":"Association of Plasma Fibrinogen and Insulin Resistance in Women with Gestational Diabetes Mellitus","volume":"6","author":"Mahjabeen","year":"2022","journal-title":"Arch. Clin. Biomed. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11102-013-0467-3","article-title":"Thrombin Generation in Cushing\u2019s Syndrome: Do the Conventional Clotting Indices Tell the Whole Truth?","volume":"17","author":"Koutroumpi","year":"2014","journal-title":"Pituitary"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5937\/jomb0-56538","article-title":"Role of Coagulation Irregularities in Cholangiocarcinoma: A review","volume":"45","author":"Hamid","year":"2025","journal-title":"J. Med. Biochem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40200-018-0347-5","article-title":"Prothrombin Time, Activated Partial Thromboplastin Time and Platelet Counts of Type II Diabetes Mellitus: A Comparative Study","volume":"17","author":"Ambelu","year":"2018","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Sapkota, B., Shrestha, S.K., and Poudel, S. (2013). Association of Activated Partial Thromboplastin Time and Fibrinogen Level in Patients with Type II Diabetes Mellitus. BMC Res. Notes, 6.","DOI":"10.1186\/1756-0500-6-485"},{"key":"ref_99","first-page":"469","article-title":"Shortened Activated Partial Thromboplastin Time and Increased Superoxide Dismutase Levels Are Associated with Type 2 Diabetes Mellitus","volume":"48","author":"Fu","year":"2018","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2337\/diabetes.55.01.06.db05-1026","article-title":"Effects of Hyperglycemia and Hyperinsulinemia on Circulating Tissue Factor Procoagulant Activity and Platelet CD40 Ligand","volume":"55","author":"Vaidyula","year":"2006","journal-title":"Diabetes"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Sillen, M., and Declerck, P.J. (2021). A narrative review on plasminogen activator inhibitor-1 and its (patho) physiological role: To target or not to target?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052721"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Mossberg, K., Olausson, J., Fryk, E., Jern, S., Jansson, P.A., and Brogren, H. (2022). The Role of the Platelet Pool of Plasminogen Activator Inhibitor-1 in Well-Controlled Type 2 Diabetes Patients. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0267833"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.ajpath.2019.04.004","article-title":"A Noncanonical Role for Plasminogen Activator Inhibitor Type 1 in Obesity-Induced Diabetes","volume":"189","author":"Coudriet","year":"2019","journal-title":"Am. J. Pathol."},{"key":"ref_104","first-page":"390185","article-title":"Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity","volume":"2015","author":"Singh","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4236\/ojemd.2017.76013","article-title":"Genetic and Metabolic Determinants of Plasminogen Activator Inhibitor 1 (PAI-1) in Tunisian Type 2 Diabetes Patients","volume":"7","author":"Moustapha","year":"2017","journal-title":"Open J. Endocr. Metab. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"17714","DOI":"10.1038\/srep17714","article-title":"Plasminogen Activator Inhibitor-1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis of Observational Studies","volume":"6","author":"Yarmolinsky","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/ATVBAHA.107.160168","article-title":"Plasminogen Activator Inhibitor-1 Activity in Type 2 Diabetes: A Different Relationship with Coronary Heart Disease and Diabetic Retinopathy","volume":"28","author":"Brazionis","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1203\/01.PDR.0000164307.92308.09","article-title":"Plasminogen Activator Inhibitor-1 and Tissue-Plasminogen Activator in Minority Adolescents with Type 2 Diabetes and Obesity","volume":"58","author":"Umpaichitra","year":"2005","journal-title":"Pediatr. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13098-022-00900-2","article-title":"Plasminogen Activator Inhibitor 1 and Gestational Diabetes: The Causal Relationship","volume":"14","author":"Batiha","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s13410-024-01352-2","article-title":"Plasminogen Activator Inhibitor-1 Levels in Prior Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis","volume":"45","author":"Tiongco","year":"2024","journal-title":"Int. J. Diabetes Dev. Ctries."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2265.2008.03181.x","article-title":"Amelioration of Cardiovascular Risk Factors with Partial Biochemical Control of Acromegaly","volume":"69","author":"Delaroudis","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1523-1755.2005.00207.x","article-title":"Plasminogen Activator Inhibitor-1 Deficiency Retards Diabetic Nephropathy","volume":"67","author":"Nicholas","year":"2005","journal-title":"Kidney Int."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12886-022-02550-4","article-title":"Relationship between Serum and Tear Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Diabetic Retinopathy","volume":"22","author":"Jasmiad","year":"2022","journal-title":"BMC Ophthalmol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.2337\/db14-1192","article-title":"Role of Plasminogen Activator Inhibitor-1 in Glucocorticoid-Induced Diabetes and Osteopenia in Mice","volume":"64","author":"Tamura","year":"2015","journal-title":"Diabetes"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/s-2008-1040762","article-title":"Circulating thrombomodulin levels and clinical correlates in pregnant diabetics","volume":"14","author":"Magriples","year":"1997","journal-title":"Am. J. Perinatol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/00365513.2023.2168566","article-title":"Use of Thrombomodulin-Modified Thrombin Generation in Uncomplicated Pregnancy: The Normal Range and Prothrombotic Phenotype","volume":"83","author":"Dong","year":"2023","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Cheng, L., Fu, Q., Zhou, L., Fan, Y., Liu, F., Fan, Y., Zhang, X., Lin, W., and Wu, X. (2022). D-Dimer as a Predictor of Cardiovascular Outcomes in Patients with Diabetes Mellitus. BMC Cardiovasc. Disord., 22.","DOI":"10.1186\/s12872-022-02531-x"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3904\/kjim.1992.7.2.81","article-title":"Plasma t-PA and PAI- 1 antigen concentrations in non-insulin dependent diabetic patients: Effects of treatment modality on fibrinolysis","volume":"7","author":"Cho","year":"1992","journal-title":"Korean J. Intern. Med."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Yu, Y., Li, W., Xu, L., and Wang, Y. (2023). Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1124353"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Altalhi, R., Pechlivani, N., and Ajjan, R.A. (2021). PAI-1 in diabetes: Pathophysiology and role as a therapeutic target. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22063170"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.amjmed.2003.08.014","article-title":"Effect of plasminogen activator inhibitor\u20131 in diabetes mellitus and cardiovascular disease","volume":"115","author":"Lyon","year":"2003","journal-title":"Am. J. Med."},{"key":"ref_122","first-page":"1242","article-title":"Endothelial function in patients with newly diagnosed type 2 diabetes receiving early intensive insulin therapy","volume":"25","author":"Tian","year":"2012","journal-title":"Am. J. Hypertens."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Okano, Y., Takeshita, A., Yasuma, T., Toda, M., Nishihama, K., Fridman D\u2019Alessandro, V., and Gabazza, E.C. (2021). Protective role of recombinant human thrombomodulin in diabetes mellitus. Cells, 10.","DOI":"10.3390\/cells10092237"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ajpath.2021.02.002","article-title":"Reduced glomerular endothelial thrombomodulin is associated with glomerular macrophage infiltration in diabetic nephropathy","volume":"191","author":"Dijkstra","year":"2021","journal-title":"Am. J. Pathol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00125-013-3115-6","article-title":"Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-\u03baB\/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis","volume":"57","author":"Yang","year":"2014","journal-title":"Diabetologia"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"8089754","DOI":"10.1155\/mi\/8089754","article-title":"Recombinant Thrombomodulin Domain 1 Promotes Diabetic Corneal Wound Healing by Inhibiting HMGB1 Production and NLRP3 Inflammasome","volume":"2026","author":"Chen","year":"2026","journal-title":"Mediat. Inflamm."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/jid.2015.32","article-title":"Thrombomodulin promotes diabetic wound healing by regulating toll-like receptor 4 expression","volume":"135","author":"Cheng","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e40330","DOI":"10.1097\/MD.0000000000040330","article-title":"Comparison of clinical characteristics, microvascular complications and inflammatory markers in type 2 diabetic patients under insulin versus metformin treatment: A cross-sectional study at Karbala Diabetic Center, Iraq","volume":"103","author":"Mohammed","year":"2024","journal-title":"Medicine"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e220110","DOI":"10.1530\/EC-22-0110","article-title":"Effect of metformin on reducing platelet dysfunction in gestational diabetes mellitus: A randomized controlled trial","volume":"11","author":"Hantrakun","year":"2022","journal-title":"Endocr. Connect."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00276813","article-title":"Plasma beta-thromboglobulin in diabetes mellitus","volume":"18","author":"Borsey","year":"1980","journal-title":"Diabetologia"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1681\/ASN.20223311S1108b","article-title":"Truncated suPAR simultaneously causes kidney disease and autoimmune diabetes mellitus","volume":"33","author":"Zhu","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/db09-1008","article-title":"Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin","volume":"59","author":"Gerrits","year":"2010","journal-title":"Diabetes"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"581","DOI":"10.21037\/cdt.2018.10.14","article-title":"Tissue factor: Newer concepts in thrombosis and its role beyond thrombosis and hemostasis","volume":"8","author":"Cimmino","year":"2018","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/jth.15680","article-title":"Thrombomodulin and pregnancy in the limelight: Insights into the therapeutic aspect of thrombomodulin in pregnancy complications","volume":"20","author":"Oda","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"103704","DOI":"10.1016\/j.jri.2022.103704","article-title":"Thrombomodulin as a new therapeutic target for preeclampsia","volume":"153","author":"Takeshi","year":"2022","journal-title":"J. Reprod. Immunol."},{"key":"ref_136","first-page":"247","article-title":"Acacia nilotica leave extract and glyburide: Comparison of fasting blood glucose, serum insulin, \u03b2-thromboglubulin levels and platelet aggregation in streptozotocin induced diabetic rats","volume":"61","author":"Asad","year":"2011","journal-title":"JPMA-J. Pak. Med. Assoc."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/4\/648\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:59:27Z","timestamp":1776081567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/4\/648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,12]]},"references-count":136,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["life16040648"],"URL":"https:\/\/doi.org\/10.3390\/life16040648","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,12]]}}}